Apyx Medical Corporation
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Apyx Medical Corporation's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 19% in 3 years; of every extra $100 of sales, $144 became extra profit. Higher than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-13.2×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 54% of Healthcare companies in United States.
Cash Locked Ratio
$42For every $100 of sales, $42 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $57 tied up three years earlier.
More money tied up than 84% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
$144Sales grew 19% in 3 years; of every extra $100 of sales, $144 became extra profit.
Higher than 85% of Healthcare companies in United States.
Asset Productivity Ratio
+19% / +29%In 3 years sales changed by +19% while total assets changed by +29%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-18.7×Operating cash was negative last year, while some debt falls due within a year.
Lower than 53% of Healthcare companies in United States.
Cash Cushion Ratio
−7%Debt, after subtracting cash, equals 7% of its market value (net debt).
Lower than 77% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Apyx Medical Corporation made a loss over the last year. Apyx Medical Corporation owes $0.82 for every $1 it owns. Apyx Medical Corporation made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossApyx Medical Corporation made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
9.52The share price is 9.52 times Apyx Medical Corporation's book value per share, higher than 86% of Healthcare companies in United States.
Market cap
$102 MThe total market value of all of Apyx Medical Corporation's shares at today's price (share price × number of shares), smaller than 65% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$11 MWhat Apyx Medical Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.25Net worth divided by the number of shares. The share price of $2.41 is 9.5 times this, which is the P/B above.
Return on equity (ROE)
-90.7%Apyx Medical Corporation lost 90.7% of its shareholders' money over the last year, lower than 68% of Healthcare companies in United States.
Owes vs Owns
0.82×Apyx Medical Corporation owes $0.82 for every $1 it owns (high), higher than 79% of Healthcare companies in United States.
Dividend yield
NoneApyx Medical Corporation does not currently pay a dividend.
Revenue growth
+10%Revenue rose 10% in the year to Dec 2025, and grew 6% a year on average over 3 years.
Profit growth
LossApyx Medical Corporation made a loss in each of the last two years.
Profit margin
-21.2%Apyx Medical Corporation lost $21 for every $100 of revenue.
Interest cover
Not coveredApyx Medical Corporation's operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtApyx Medical Corporation had $8 M more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Apyx Medical Corporation: $102 M ÷ $11 M (30 Jun 2026) = 9.5.
What is Apyx Medical Corporation's return on equity?
Apyx Medical Corporation lost 90.7% of its shareholders' money over the last year, lower than 68% of Healthcare companies in United States.
How much does Apyx Medical Corporation owe compared with what it owns?
Apyx Medical Corporation owes $0.82 for every $1 it owns (high), higher than 79% of Healthcare companies in United States.
Does Apyx Medical Corporation pay a dividend?
No. Apyx Medical Corporation does not currently pay a dividend.
Is Apyx Medical Corporation's revenue growing?
Revenue rose 10% in the year to Dec 2025, and grew 6% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.